China vs Least developed countries: Immunization, measles second dose
China
95.0%
in 2024
Least developed countries
58.3%
in 2024
China rank
33rd
Least developed countries rank
35th
Immunization, measles second dose over time
- China
- Least developed countries
How they compare
China currently reports 95.0% against 58.3% in Least developed countries, a difference of 36.7%.
That makes China's figure about 1.6 times Least developed countries's.
Across all 20 years both countries report, China has been ahead every year.
China ranks 33rd and Least developed countries ranks 35th of 178 countries.
China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Least developed countries | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.6% | 2.6% | 90.0% | China |
| 2010s | 98.9% | 24.7% | 74.2% | China |
| 2020s | 97.4% | 48.7% | 48.7% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, China or Least developed countries?
- China, at 95.0% against 58.3% in Least developed countries as of 2024.
- What is the difference in immunization, measles second dose between China and Least developed countries?
- 36.7%, with China ahead.
- How many years of comparable data are there for China and Least developed countries?
- 20 years are reported by both, from 2005 to 2024.
- How do China and Least developed countries rank globally for immunization, measles second dose?
- China ranks 33rd and Least developed countries ranks 35th of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.